ACLARION, INC. Retained Earnings
ACLARION, INC. (ACON) had Retained Earnings of -$64.10 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$64.10M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$61.35M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$58.50M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$56.61M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$64.10M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$61.35M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | -$58.50M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$56.61M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$54.90M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$53.30M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | -$51.26M 10-K · filed 2026-03-18 | |
| 2024-09-30 | -$49.27M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$47.92M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$46.68M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$44.28M 10-K · filed 2025-04-09 | |
| 2023-09-30 | -$43.02M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$42.02M 10-Q · filed 2023-08-25 | |
| 2023-03-31 | -$40.55M 10-Q · filed 2023-07-03 | |
| 2022-12-31 | -$39.37M 10-K · filed 2024-03-28 | -$39.91M 10-K · filed 2023-02-27 |
| 2022-09-30 | -$38.43M 10-K/A · filed 2023-06-12 | -$38.58M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$36.79M 10-Q · filed 2023-08-25 | -$36.95M 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$33.11M 10-Q · filed 2022-06-06 | |
| 2021-12-31 | -$31.89M 10-K/A · filed 2023-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |